U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
The Parent Company was added by ICIJ.
The parent company information is based on 2017 public records.
데이터 추가 비고
Accelerator, linear, medical - Product Code IYE
원인
Xvi can incorrectly calculate the target position of the treatment table.
조치
Elekta is responsible for the correction of all products with this defect.
1. Notifications regarding the possibility of this software error and subsequent table location error and potential hazards have been sent out. The notifications include steps to take to reduce the possibility of the occurrence of an injury.
2. A software correction has been released for some versions of the XVI software. All versions of software with this error will be corrected by the end of July 2014.
3. The software correction will enable verification that values have been assigned to table position parameters; failure to pass verification will inhibit the system. The software correction will also detect internal communication errors (incomplete registrations) and inhibit the system when those errors are detected.
4. The update will be mandatory and will be made at no cost to the users.
CDRH approves this CAP. You may proceed with implementation of the CAP.
For further questions please call (770) 670-2422.
Worldwide Distribution - USA including the states of AZ, CT, IA, OH, MD, MI, MN, NV, TX and VA., and the countries of India, Ireland, Malta, Netherlands, South Africa and UK.
제품 설명
Synergy XVI || Intended for radiation therapy treatment.